ARTICLE | Clinical News
Theratope STn-KLH: Filed IND to begin a U.S. Phase II trial
September 27, 1993 7:00 AM UTC
Biomira Inc. (BIOMF) Product: Theratope STn-KLH, synthetic carbohydrate therapeutic vaccine Indication: Breast cancer Status: Filed IND to begin a U.S. Phase II trial in 45 patients, using data from i...